The global Duchenne muscular dystrophy therapeutics market, valued at US$2.19 billion in 2024, is projected to reach US$6.64 billion by 2033 at a 13.2% CAGR. Explore drivers like novel gene therapies (Elevidys, Viltepso), rising R&D funding, and exon-skipping innovations amid increasing awareness and orphan drug support. https://finance.yahoo.com/news/duchenne-muscular-dystrophy-therapeutics-market-083800204.html